The Morning Call
Registration of an Ebola vaccine is expected in additional countries in the coming weeks as the Democratic Republic of the Congo (DRC), Burundi, Ghana and Zambia give license just 90 days after World Health Organization (WHO) prequalification.
So what does this news mean in the global fight against the haemorrhagic disease? Well, first, the licensing of the vaccine means that the manufacturer can stockpile and widely distribute this vaccine to African countries at risk of Ebola virus disease outbreaks. Once licensed doses are available, use of the vaccine will not require clinical trial or other research protocols.
Go to video
Uganda: 17 people died of anthrax in November
02:16
Mozambique tackles tuberculosis in Maputo's prisons
00:10
Zimbabwe: cholera patients treated in epicentre of Kuwadzana
01:50
Congo strugles to care for stroke victims
Go to video
Burkina: 214 deaths from dengue since January 1
Go to video
Outbreak of diphtheria kills 600 in Nigeria